Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric
emptying, gastric accommodation, satiety, and satiation in obese participants.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)